Claudin 18.2 antibodies, antigen binding fragments and antibody drug conjugates thereof and methods of use in cancer therapy

TW202637594APending Publication Date: 2026-09-16ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146134
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-27
Filing Date
2025-11-26
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076535_001
    Figure TWG2TA001076535_001
  • Figure TWG2TA001076535_002
    Figure TWG2TA001076535_002
  • Figure TWG2TA001076535_003
    Figure TWG2TA001076535_003
Patent Text Reader

Abstract

expressing cells, along with pharmaceutical compositions and kits comprising the antibodies, antigen binding fragments, and / or immunoconjugates. Methods of use of the antibodies, antigen binding fragments, and immunoconjugates in the treatment of claudin
Need to check novelty before this filing date? Find Prior Art